C54.1 - Malignant neoplasm of endometrium

Version 2023
Billable Code
Diagnoses For Females Only
MS-DRG Mapping
Convert to ICD-9
Primary Malignant Neoplasm
ICD-10:C54.1
Short Description:Malignant neoplasm of endometrium
Long Description:Malignant neoplasm of endometrium
Status: Valid for Submission
Version:ICD-10-CM 2023
Code Classification:
  • Neoplasms (C00–D48)
    • Malignant neoplasms of female genital organs (C51-C58)
      • Malignant neoplasm of corpus uteri (C54)

C54.1 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of endometrium. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.

This code is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.

The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic endometrium (gland) (stroma) or Neoplasm, neoplastic stroma, endometrial or Neoplasm, neoplastic uterus, uteri, uterine endometrium .

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Index to Diseases and Injuries References

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:

Convert to ICD-9 Code

Source ICD-10 CodeTarget ICD-9 Code
C54.1182.0 - Malig neo corpus uteri
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Neoplasms

This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary		 Malignant
Secondary		 CaInSitu Benign Uncertain
Behavior		 Unspecified
Behavior
»Neoplasm, neoplastic
  »endometrium (gland) (stroma)
C54.1C79.82D07.0D26.1D39.0D49.59
»Neoplasm, neoplastic
  »stroma, endometrial
C54.1C79.82D07.0D26.1D39.0D49.59
»Neoplasm, neoplastic
  »uterus, uteri, uterine
    »endometrium
C54.1C79.82D07.0D26.1D39.0D49.59

Patient Education


Uterine Cancer

The uterus, or womb, is the place where a baby grows when a women is pregnant. There are different types of uterine cancer. The most common type starts in the endometrium, the lining of the uterus. This type is also called endometrial cancer.

The symptoms of uterine cancer include:

Uterine cancer usually happens after menopause. It is more common in women who have obesity. You also have a higher risk if you took estrogen-only hormone replacement therapy (menopausal hormone therapy) for many years.

Tests to find uterine cancer include a pelvic exam, imaging tests, and a biopsy. The most common treatment is a hysterectomy, which is surgery to remove the uterus. Sometimes the surgery also removes the ovaries and fallopian tubes. Other treatments include hormone therapy, radiation therapy, and chemotherapy. Some women get more than one type of treatment.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

Previous Code: C54.0

Parent Code: C54

Next Code: C54.2